Follow
Sylvain Garciaz
Sylvain Garciaz
Institut Paoli-Calmettes
Verified email at ipc.unicancer.fr
Title
Cited by
Cited by
Year
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: a series from lysa centers
C Rossi, J Gilhodes, M Maerevoet, C Herbaux, F Morschhauser, P Brice, ...
American journal of hematology 93 (8), 1042-1049, 2018
992018
Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous …
A de Masson, M Beylot-Barry, JD Bouaziz, RP de Latour, F Aubin, ...
haematologica 99 (3), 527-534, 2014
832014
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in …
X Leleu, G Fouquet, B Hebraud, M Roussel, D Caillot, ML Chrétien, ...
Leukemia 27 (11), 2242-2244, 2013
762013
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma
S Garciaz, D Coso, F Peyrade, S Fürst, S Duran, B Chetaille, ...
Hematological oncology 32 (4), 187-191, 2014
682014
Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): results of a French multicenter study of 474 patients from LYmphoma Study Association …
SP Chantepie, S Garciaz, E Tchernonog, F Peyrade, MV Larcher, M Diouf, ...
American journal of hematology 93 (6), 729-735, 2018
462018
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity
S Garciaz, D Coso, JM Schiano de Collela, F Broussais, AM Stoppa, ...
Bone Marrow Transplantation 51 (2), 319-321, 2016
442016
Azacitidine plus venetoclax for the treatment of relapsed and newly diagnosed acute myeloid leukemia patients
S Garciaz, MA Hospital, AS Alary, C Saillard, Y Hicheri, B Mohty, J Rey, ...
Cancers 14 (8), 2025, 2022
372022
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity
M Koubi, M Poplineau, J Vernerey, L N’Guyen, G Tiberi, S Garciaz, ...
Nucleic acids research 46 (7), 3339-3350, 2018
302018
Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites
E Mamessier, C Drevet, F Broussais-Guillaumot, ML Mollichella, ...
Haematologica 100 (4), e155, 2015
272015
Pharmacologic reduction of mitochondrial iron triggers a noncanonical BAX/BAK-dependent cell death
S Garciaz, AA Guirguis, S Müller, FC Brown, YC Chan, A Motazedian, ...
Cancer Discovery 12 (3), 774-791, 2022
262022
Patients’ non-medical characteristics contribute to collective medical decision-making at multidisciplinary oncological team meetings
L Restivo, T Apostolidis, AD Bouhnik, S Garciaz, T Aurran, ...
PLoS One 11 (5), e0154969, 2016
242016
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a …
T Hueso, T Gastinne, S Garciaz, E Tchernonog, C Delette, ...
Bone marrow transplantation 55 (6), 1076-1084, 2020
232020
Lenalidomide for the treatment of B-cell lymphoma
S Garciaz, D Coso, JM Schiano de Colella, R Bouabdallah
Expert Opinion on Investigational Drugs 25 (9), 1103-1116, 2016
232016
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
JE Martin, S Khalife-Hachem, T Grinda, M Kfoury, S Garciaz, F Pasquier, ...
Annals of Oncology 32 (8), 1046-1048, 2021
222021
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, S Fürst, S Bramanti, D Coso, ...
Bone marrow transplantation 50 (6), 865-867, 2015
222015
A first-in-human phase 1 study of the menin-KMT2A (MLL1) inhibitor JNJ-75276617 in adult patients with relapsed/refractory acute leukemia harboring KMT2A or NPM1 alterations
E Jabbour, E Searle, M Abdul-Hay, S Abedin, I Aldoss, AA Piérola, ...
Blood 142, 57, 2023
212023
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses
KL Chan, J Gomez, C Cardinez, N Kumari, CE Sparbier, EYN Lam, ...
Cancer Cell 40 (10), 1190-1206. e9, 2022
172022
Venetoclax in acute myeloid leukemia: molecular basis, evidences for preclinical and clinical efficacy and strategies to target resistance
S Garciaz, C Saillard, Y Hicheri, MA Hospital, N Vey
Cancers 13 (22), 5608, 2021
152021
Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a …
S Garciaz, M Loschi, A De Masson, L Biard, M Mercier, C Tomowiak, ...
Leukemia & Lymphoma, 2019
152019
Therapy-related myeloid neoplasms following PARP inhibitors: real-life experience
V Marmouset, J Decroocq, S Garciaz, G Etienne, A Belhabri, S Bertoli, ...
Clinical Cancer Research 28 (23), 5211-5220, 2022
142022
The system can't perform the operation now. Try again later.
Articles 1–20